Apr 23, 2025
Debiopharm to Reveal Insights From Their ADC, DDR Inhibitor, and Antibody Conjugation Technology Research at the 2025 AACR Conference in Chicago
Apr 21, 2025
Single Use Bioreactors Market Industry Trends and Global Forecasts to 2035: Over 400 Patents Filed for Single-Use Bioreactors, Reflecting Growing Industry Innovation - ResearchAndMarkets.com
Apr 17, 2025
Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Greater San Diego to Help Accelerate Cell Therapy Development
Apr 17, 2025
ViroCell Manufactured a GMP Lentiviral Vector for UCL to Accelerate Research Into Prevention of Relapse in Childhood Blood Cancer
Apr 16, 2025
Innovive Expands into Latin America & Caribbean Through a New Distribution Partnership with EAD Scientific
Apr 16, 2025
EveryONE Medicines Announces Appointment of Michelle L. Mellion, MD, as Chief Medical Officer
Apr 14, 2025
Aptar Digital Health Reports Positive Impact of iPUMP® on Sublingual Liquid Allergen Immunotherapy Adherence
Apr 10, 2025
Cellares and University of Wisconsin School of Medicine and Public Health to Automate Clinical-Scale Production of CRISPR-Edited CAR-T for Solid Tumors
Apr 09, 2025
Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 1, Multiple Ascending Dose LUMINA Trial of AMX0114 in People Living with Amyotrophic Lateral Sclerosis
Apr 03, 2025
Meitheal Pharmaceuticals Announces Approval and Launch of Liraglutide Injection in the United States
Mar 28, 2025
Altasciences Receives 2025 CDMO Leadership Award in Small Molecule Dosage Form Category
Mar 28, 2025
National Cancer Center Japan and PeptiDream: New Radiopharmaceuticals for Renal Cell Carcinoma
Mar 27, 2025
ViroCell Biologics Appoints Viral Vector Expert as Special Advisor
Mar 25, 2025
Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein(a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Mar 11, 2025
RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter Into a Strategic Partnership to Manufacture FDA Approved Cell Therapy Omisirge® (omidubicel-onlv)
Feb 25, 2025
Humanetics Corporation Chief Medical Officer Is Featured Guest at U.S. Industry, National Security, and Healthcare Forum
Feb 24, 2025
Cellino Launches U.S.’s First Nebula-Powered iPSC Foundry for Scalable Autologous Biomanufacturing
Feb 20, 2025
KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
Feb 18, 2025
GeminiBio Appoints Mike Stella to Board
Feb 06, 2025
Axena Health Enters Into Collaboration with Mayo Clinic to Expand Education and Advance First-Line Care for Female Urinary Incontinence